Is your dog (and even possibly you) going to live longer with the help of a drug used to prevent organ transplant rejection?
The Doctors discuss an upcoming study of the drug rapamycin which will be used in a double-blind placebo-controlled trial of 500 middle-aged dogs. The drug is currently used to prevent organ rejection in people, but research has found that it extends the life of mice. It has been shown to improve metabolism, cardiac function, cognition abilities.
Researcher from the Dog Aging Project Matt Kaeberlein explains that mice who get rapamycin live 15 to 25 percent longer, along with delayed age-related health issues. He hopes his study will find the same positive benefits for dogs.
Rapamycin might have benefits in animals, but what about in humans?
Cardiologist Dr. Joel Kahn says there is still a great deal to be learned about the possible health benefits of this drug in humans, and notes there are only a few small studies of the drug being used on humans so far. He says he is asked about the drug often by patients, and while he is hopeful, Dr. Kahn notes there are still questions about how rapamycin may affect someone's cholesterol, blood sugar, and immune system.
Find out more information on the Dog Aging Project.